InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: Luckydogs2017 post# 287

Saturday, 02/25/2017 4:08:08 PM

Saturday, February 25, 2017 4:08:08 PM

Post# of 1109
Last news was Feb 13:

Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine

http://ir.zosanopharma.com/releasedetail.cfm?ReleaseID=1011563

Know What You Own. My posts should not be construed as investment advice.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.